Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Small Cell Lung Carcinoma Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Platinum Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences
Survival Rate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2006 2021

Research Output 2005 2017

  • 353 Citations
  • 12 Scopus h-Index
  • 21 Article
  • 5 Review article
  • 2 Chapter
  • 1 Editorial

Advances in Small Cell Lung Cancer

Kalemkerian, G. P. & Schneider, B. J. Feb 1 2017 In : Hematology/Oncology Clinics of North America. 31, 1, p. 143-156 14 p.

Research output: Contribution to journalReview article

Small Cell Lung Carcinoma
Cranial Irradiation
Neuroendocrine Tumors
Chemoradiotherapy
Smoking
5 Citations

Personalized therapy of small cell lung cancer

Schneider, B. J. & Kalemkerian, G. P. Oct 1 2016 Advances in Experimental Medicine and Biology. Springer New York LLC, Vol. 890, p. 149-174 26 p. (Advances in Experimental Medicine and Biology; vol. 890)

Research output: Chapter in Book/Report/Conference proceedingChapter

Inborn Errors Amino Acid Metabolism
Small Cell Lung Carcinoma
Contraception Behavior
Castration
Erythrasma

Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer

Schneider, B. J., Kalemkerian, G. P., Gadgeel, S. M., Valdivieso, M., Hackstock, D. M., Chen, W., Heilbrun, L. K., Ruckdeschel, J. C. & Wozniak, A. J. Jul 28 2016 In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Confidence Intervals
Survival Rate
Disease-Free Survival
Safety

Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent

Saxena, A., Schneider, B. J., Christos, P. J., Audibert, L. F., Cagney, J. M. & Scheff, R. J. Feb 1 2016 In : Medical Oncology. 33, 2, p. 1-9 9 p., 13

Research output: Contribution to journalArticle

Paclitaxel
Platinum
Non-Small Cell Lung Carcinoma
Nanoparticles
Albumins
28 Citations

Chemotherapy use, performance status, and quality of life at the end of life

Prigerson, H. G., Bao, Y., Shah, M. A., Elizabeth Paulk, M., LeBlanc, T. W., Schneider, B. J., Garrido, M. M., Carrington Reid, M., Berlin, D. A., Adelson, K. B., Neugut, A. I. & MacIejewski, P. K. Sep 1 2015 In : JAMA Oncology. 1, 6, p. 778-784 7 p.

Research output: Contribution to journalArticle

Quality of Life
Drug Therapy
Neoplasms
Odds Ratio
Medical Oncology